HAVE YOU TAKEN Brodalumab FOR YOUR PSORIASIS?
We need approximately 15 minutes of your time TODAY! You could win an iPad Mini!
Please help all of us who struggle with psoriasis by completing this short but very important questionnaire by December 15th, 2017. Your input could help make the difference in getting this drug covered in Canada for psoriasis!
The Canadian Association of Psoriasis Patients (CAPP) and the Canadian Skin Patient Alliance (CSPA) are non-profit organizations created to support patients as they strive to get access to treatment that works for them. We offer support, information and education about psoriasis, psoriatic arthritis and other dermatological conditions.
Why your participation really matters – it could affect you...
Canada's Common Drug Review (CDR) is a body that conducts a clinical and economic review of new drugs that are being considered for funding in Canada. The CDR welcomes the input of patients through registered patient organizations like the CSPA to help them make recommendations on whether a drug should be funded by the provincial health ministries or not. In addition, many private insurance companies are also increasingly looking to these ‘recommendations’ to help them decide on whether or not they should cover a medication for their policy-holders.
All responses are kept confidential and collated into one document describing patients’ experience with their condition and with the new medication. You will not be identified in any way unless you give us permission to contact you for a phone interview. We are independent from both the drug company and the government and we do this work to make sure that as many people can get access to important new and effective medications as quickly as possible.
Please take a few moments to tell us about your experiences by filling out this short survey. If you provide your contact information, your name will be added to a draw for the iPad Mini.
Thank you for participating and doing your part to help Canadians get access to new and effective treatments for psoriasis.